Two-step enhanced cancer immunotherapy with engineered Salmonella typhimurium secreting heterologous flagellin
The DOI matches its Crossref record; 53 of the 54 references it cites were found in a registry or an index.
Abstract
Engineered Salmonella secreting heterologous bacterial flagellin suppress tumor growth by activating intratumoral macrophages.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“with intratumoral or intravenous injection often leading to ~10,000-fold accumulation in tumors relative to matched liver, spleen, and lung tissues (152, 153).”
From The microbiome and human cancer (2021) · cites this paper as [152]
Citations
Cites
Exploiting tumour hypoxia in cancer treatment
Brown, J. M., & Wilson, W. R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1367 · Cited by 2,828 · cited 1×
“INTRODUCTION Abnormal blood vessels and hypoxic and necrotic regions are universal features of solid tumors (1, 2).”
BackgroundKigerl, K. A., Gensel, J. C., Ankeny, D. P., Alexander, J. K., Donnelly, D. J., & Popovich, P. G. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.3257-09.2009 · Cited by 2,130 · cited 1×
“The engrafted MC38 tumor tissues were removed from C57BL/6 WT mice 24 hours after induction of FlaB and triple-stained with CD45, F4/80, and CD206 (to detect M2-type macrophages) or with CD45, F4/80, and CD86 (to detect M1-type macrophages) (32, 33).”
MethodTargeted Disruption of the MyD88 Gene Results in Loss of IL-1- and IL-18-Mediated Function
Adachi, O., Kawai, T., Takeda, K., Matsumoto, M., Tsutsui, H., Sakagami, M., Nakanishi, K., & Akira, S. (1998) · Immunity · doi:10.1016/s1074-7613(00)80596-8 · Cited by 2,041 · cited 1×
“TLR4, TLR5, and MyD88 knockout mice with a C57BL/6 genetic background were described previously (47, 48).”
MethodMolecular Mechanisms That Influence the Macrophage M1–M2 Polarization Balance
Wang, N., Liang, H., & Zen, K. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00614 · Cited by 1,980 · cited 10×
“The in vitro stimulation of cancer cells with FlaB did not increase phosphorylation of NF-kB p65 (fig.”
BackgroundInfluentialThe Isolation and Characterization of Murine Macrophages
Zhang, X., Goncalves, R., & Mosser, D. M. (2008) · Current Protocols in Immunology · doi:10.1002/0471142735.im1401s83 · Cited by 1,536 · cited 1×
“Cell preparation and FACS analysis Peritoneal macrophages were isolated from specific pathogen–free C57BL/6 male mice, as described previously (50).”
MethodToll-like receptors and cancer
Rakoff-Nahoum, S., & Medzhitov, R. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2541 · Cited by 925
Two FOXP3+CD4+ T cell subpopulations distinctly control the prognosis of colorectal cancers
Saito, T., Nishikawa, H., Wada, H., Nagano, Y., Sugiyama, D., Atarashi, K., Maeda, Y., Hamaguchi, M., Ohkura, N., Sato, E., et al. (2016) · Nature Medicine · doi:10.1038/nm.4086 · Cited by 871 · cited 1×
“Because the background signals in experimental groupswere different, whichmay be due to different degrees of cell injury resulting from the different modes of treatment (PBS, empty Salmonella, and FlaB-secreting Salmonella), we adjusted gating parameters for the FACS analysis of different groups (51, 52).”
MethodTherapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists
Kanzler, H., Barrat, F. J., Hessel, E. M., & Coffman, R. L. (2007) · Nature Medicine · doi:10.1038/nm1589 · Cited by 869 · cited 1×
“Because of accumulating reports that activating various TLRs resulted in antitumor effects (31, 37–41), many TLRspecific agonists are currently being investigated for tumor immunotherapy (37).”
BackgroundBiswas, S. K. (2006) · Blood · doi:10.1182/blood-2005-01-0428 · Cited by 696
Toso, J. F. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.1.142 · Cited by 614 · cited 1×
“VNP20009, an attenuated strainof Salmonella typhimurium with purI and msbB gene deletions, was safely administered to patients with metastatic melanoma and renal cell carcinoma in a phase 1 study, where substantial tumor colonization was observed (11, 12).”
Research works printed but not linked: 1
- 10.1200/jco.2002.20.1.142 · DOI · Paper page
Cited by
Items 401–500 of 627
Anti-glioma effect of intracranial vaccination with tumor cell lysate plus flagellin in mice
Dong, B., Wang, L., Nie, S., Li, X., Xiao, Y., Yang, L., Meng, X., Zhao, P., Cui, C., Tu, L., et al. (2018) · Vaccine · doi:10.1016/j.vaccine.2018.04.053 · Cited by 8
Bugs as Drugs, potential self-regenerated innovative cancer therapeutics approach for global health
Salicrup, L. A., Ossandon, M. R., Prickril, B., & Rasooly, A. (2020) · Journal of Global Health · doi:10.7189/jogh.10.010311 · Cited by 8
Zhang, W., Piao, L., & Liu, X. (2020) · Journal of Functional Foods · doi:10.1016/j.jff.2020.104216 · Cited by 8
Microbes in Oncology: Controllable Strategies for Bacteria Therapy
Du, M., Yu, J., Yang, Y., Yan, F., & Chen, Z. (2020) · BIO Integration · doi:10.15212/bioi-2020-0025 · Cited by 8
Jin, X., An, S., Kightlinger, W., Zhou, J., & Hong, S. H. (2021) · AIChE Journal · doi:10.1002/aic.17466 · Cited by 8
Self-citationTrojan Nanobacteria System for Photothermal Programmable Destruction of Deep Tumor Tissues
Chu, B., Yang, Y., Tang, J., Song, B., He, Y., & Wang, H. (2022) · Angewandte Chemie · doi:10.1002/ange.202208422 · Cited by 8
Feng, J., Liu, Y., Pan, X., Jin, F., Wu, L., Chen, J., Wan, B., Zhang, X., Rodrigues, L. R., & Zhang, Y. (2022) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.2c08684 · Cited by 8
Ma, Y., Qiying, L., Hu, A., Jiang, S., Wang, S., Liu, R., Han, K., & Wang, J. (2022) · Bioengineering · doi:10.3390/bioengineering9090433 · Cited by 8
Self-citationBacterial Expression of Promelittin for Safe and Effective Tumor Therapy
Xu, W., Chen, H., Duan, Y., Ge, D., Ren, D., Zhao, S., Liu, Y., Ma, L., & Zhang, C. (2023) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.3c11457 · Cited by 8
Lu, Y., Li, Z., Xu, H., Zeng, Q., Zhu, X., Chen, K., Zheng, W., Liu, S., Guan, W., & Wu, J. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.114284 · Cited by 7
Singh, I., Abdulqadir, R. F., Verma, I. K., Awasthi, Y., Ratn, A., Sharma, J., Rawat, M., Dhakad, M. S., Dalal, J., Gupta, Y., et al. (2025) · Food Frontiers · doi:10.1002/fft2.70168 · Cited by 7
Jorge, G. P., Gontijo, M. T. P., Silva, M. F. E., Goes, I. C. R. D. S., Jaimes-Florez, Y. P., Coser, L. D. O., Rocha, F. J. S., Giorgio, S., & Brocchi, M. (2024) · Experimental Biology and Medicine · doi:10.3389/ebm.2024.10081 · Cited by 7
Research and application of intelligent diagnosis and treatment engineering bacteria
Zhao, N., Chen, J., Shi, J., Gao, Y., Li, L., & Dong, L. (2024) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2024.1524376 · Cited by 7
Zhang, H., Du, H., Sun, K., Wang, J., Li, P., Zhou, Y., & Sun, Y. (2025) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2025.110130 · Cited by 7
Hossam, N., Matboli, M., Shehata, H. H., Aboelhussein, M. M., Hassan, M. K., & Eissa, S. (2020) · Expert Review of Precision Medicine and Drug Development · doi:10.1080/23808993.2020.1816136 · Cited by 7
Investigational Microbiological Therapy for Glioma
Wang, J., Liu, Y., Zhang, A., Yu, W., Lei, Q., Xiao, B., & Luo, Z. (2022) · Cancers · doi:10.3390/cancers14235977 · Cited by 7
“Therefore, it promotes the immune response in the glioma microenvironment and inhibits tumor growth [19].”
BackgroundZeng, S.-M., Zheng, D., Li, R., Zhuang, Z., Zhang, Y., Sun, Y., & Zhang, X. (2022) · ACS Materials Letters · doi:10.1021/acsmaterialslett.2c00716 · Cited by 7
Emerging technologies for genetic control systems in cellular therapies
de Rossi, J., Arefeayne, Y., Robinson, A. J., & Segatori, L. (2022) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2022.102833 · Cited by 7
Designer Probiotics in Metabolic Disorders
Gupta, R. G., & Raghuwanshi, S. (2022) · Springer eBooks · doi:10.1007/978-981-16-8444-9_12 · Cited by 7
Hamza, M., Wang, S., Liu, Y., Li, K., Zhu, M., & Chen, L. (2025) · Microbiological Research · doi:10.1016/j.micres.2025.128156 · Cited by 6
Engineering advanced bacterial therapy for tumor and inflammatory diseases
Chen, Y., & Han, Q. (2025) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2025.125585 · Cited by 6
Bacterial Autonomous Intelligent Microrobots for Biomedical Applications
Chen, H., Li, Y., Li, Z., Sun, Y., Gu, W., Chen, C., & Cheng, Y. (2025) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.70011 · Cited by 6
Tumour-specific delivery of ω-conotoxin MVIIA via engineered Salmonella for safe anticancer therapy
Kim, E., Han, M., Jeong, M., Kim, S., Jeon, H. J., & Lee, H. J. (2025) · Journal of Advanced Research · doi:10.1016/j.jare.2025.08.060 · Cited by 6
Microbiome unlocks cancer immunotherapeutic potential: State of the art and future
Luo, H.-Y., Cao, L., Zhou, K., Xiao, Y., Li, Z., Liu, B., & Bu, L. (2025) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2025.08.001 · Cited by 6
Feng, Q., Zhang, H., Ye, G., Zhang, J., Xiao, J., Wang, Z., Zhang, J., Pan, M., Feng, J., Zhong, Y., et al. (2025) · Materials Today Bio · doi:10.1016/j.mtbio.2025.102495 · Cited by 6
Engineering microbes to modulate innate immune signaling: strategies for host–microbe interactions
Bonanno, S. L., & Joshi, N. S. (2025) · Current Opinion in Microbiology · doi:10.1016/j.mib.2025.102695 · Cited by 6
Dang, G. C., Loeurng, V., Pa, P., Seng, C. Y., Lee, S. E., & Rhee, J. H. (2026) · npj Vaccines · doi:10.1038/s41541-026-01376-1 · Cited by 6
Self-citationCrosstalk Between Intratumoral Microbes and Tumor Immunity: Implications for Tumor Therapy
Li, F., Qiao, L., Liang, X., Zhang, Y., Liang, N., Xie, J., Deng, G., Hao, Y., Hu, P., Wu, X., et al. (2026) · Cancer Medicine · doi:10.1002/cam4.71575 · Cited by 6
“This effect is associated with the TLR4 signaling pathway, promoting the transition of macrophages from the M2 to the M1 phenotype [142].”
Ahmed, S., & Brenner, G. J. (2022) · Anticancer Research · doi:10.21873/anticanres.16127 · Cited by 6
Hybrid Bacteria System with Nanomaterials for Tumor Therapy
Zhang, Q., Ma, X., & Zhao, X. (2023) · Advanced NanoBiomed Research · doi:10.1002/anbr.202300003 · Cited by 6
Xu, H., Piao, L., Liu, X., & Jiang, S. (2022) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-022-03612-2 · Cited by 6
Self-citationNomura, S., Sukowati, E. W., Shigeno, Y., Takahashi, M., Kato, A., Benno, Y., Yamashita, F., & Mukai, H. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15030989 · Cited by 6
“Gram-negative bacteria, such as Salmonella and Escherichia, carry endotoxins that exert antitumor effects by activating host immunity in tumors [7,21].”
BackgroundResultInfluentialYamazaki, K., Kashimoto, T., Hashimoto, Y., Kado, T., & Ueno, S. (2017) · Journal of Veterinary Medical Science · doi:10.1292/jvms.17-0395 · Cited by 6
“vulnificus appears to be the most crucial component of the flagellum and is known to have mucosal adjuvant activity to induce protective immunity by activating innate immune responses via the TLR5 signaling pathway [11, 19, 24].”
BackgroundInfluentialDesign of Nano-Robots for Exposing Cancer Cells
Dolev, S., Rosenblit, M., & Narayanan, R. P. (2018) · IEEE International Conference on Nanotechnology (IEEE-NANO) · doi:10.1109/nano.2018.8626359 · Cited by 6
Moon, C., Zheng, J. H., Min, J., Jeong, Y. Y., Heo, S., & Shin, S. S. (2020) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2020.06.021 · Cited by 6
Self-citationEngineering microbial living therapeutics
Pedrolli, D. B., Ribeiro, N. V., Squizato, P. N., Cozetto, D. A., de Jesus, V. N., Freire, P. J. C., Lins, M. R. C. R., & Corrêa, G. G. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-819178-1.00008-3 · Cited by 6
Huang, Y., Piao, L., & Liu, X. (2024) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2024.124759 · Cited by 5
Optimized bacterial delivery approaches for precision immunotherapy in breast cancer models
Park, J.-E., Kang, S. J., Ahn, J.-S., Choi, S.-H., Lee, J., Kim, J., & Park, S. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.114004 · Cited by 5
Self-citationHahn, J., Harimoto, T., Chen, Y.-Y., Liguori, F., Leong, K. W., & Danino, T. (2026) · ACS Synthetic Biology · doi:10.1021/acssynbio.5c00598 · Cited by 5
Wu, L., Li, C., Qiao, L., Li, L., Zhang, S., Wang, B., Sun, Y., Qiu, J., Huang, B., Qiao, X., et al. (2026) · Cell Reports · doi:10.1016/j.celrep.2025.116918 · Cited by 5
Wu, Q., Zhou, Y.-R., Chen, Z.-R., Liu, M.-X., Liu, M.-X., Liu, Y.-F., Li, Z., Zhao, Q.-R., Zhang, Y.-Q., Zhang, H., et al. (2026) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2026.105230 · Cited by 5
Intratumoral microbiota in cancer: molecular mechanism and therapeutic strategies
Yu, Y., Guo, Z., Luo, Z., Dian, Y., Yang, X., Chen, X., Zeng, F., & Deng, G. (2026) · Molecular Biomedicine · doi:10.1186/s43556-026-00473-w · Cited by 5
“S. typhimurium releasing Vibrio trauma -derived FlaB promoted an increase in M1-like macrophages via TLR4 signaling, and increased the production of pro-inflammatory cytokines such as IL-1β and TNF-α [423].”
Migration of immune cells in tumors and inflammation: molecular mechanisms and therapeutic targets
Lu, Y., Shao, D., Xiao, Y., Jiang, Y., & Shao, Z. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-026-02851-w · Cited by 5
Sun, T., Wang, M., Zhang, L., Gong, M., Xie, Q., Yang, X., Xiao, S., Zhang, W., Liu, X., Zhao, Y., et al. (2025) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.5c01645 · Cited by 5
Xu, D., Wen, M., Bingwa, L. A., Chen, X., Chen, Y., Qian, W., Yang, C., Zheng, J. H., Zhou, Y., Ni, H., et al. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03498-0 · Cited by 5
Self-citationBacterial cancer therapy using the attenuated fowl-adapted Salmonella enterica serovar Gallinarum
Lim, D., Kim, K., Duysak, T., So, E., Jeong, J., & Choy, H. E. (2023) · Molecular Therapy — Oncolytics · doi:10.1016/j.omto.2023.100745 · Cited by 5
“24, Tumor-bearing mice tolerated a dose of 10 8 CFU E. coli .”
BackgroundSelf-citationSiddiqui, N. A., Houson, H. A., Thomas, S. C., Blanco, J. R., O’Donnell, R. E., Hassett, D. J., Lapi, S. E., & Kotagiri, N. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.08.06.240119 · Cited by 5
Sun, W., Li, Y.-A., Li, Z., Li, G., Du, Y., & Shi, H. (2025) · Veterinary Microbiology · doi:10.1016/j.vetmic.2025.110546 · Cited by 4
Li, Y., Kang, X., Yu-na, S., Akter, L., VanLuinen, E., Nakkala, J. R., & Chen, X. (2025) · Scientific Reports · doi:10.1038/s41598-025-21238-5 · Cited by 4
Wang, Q., & Ding, H. (2025) · Digestive Diseases and Sciences · doi:10.1007/s10620-025-09490-1 · Cited by 4
Intratumoral microbiota in colorectal cancer: roles, therapeutic potential, and challenges
Zhang, X., Qi, J., Dong, C., Zhang, L., Chen, J., Li, M., Jiang, T., & Song, J. (2025) · Journal of Advanced Research · doi:10.1016/j.jare.2025.11.067 · Cited by 4
(2025) · Pakistan Veterinary Journal · doi:10.29261/pakvetj/2025.327 · Cited by 4
Microbiome-modulated immunotherapy in oncology: Current applications and future prospects
Liu, Y., Miao, K., & Yang, X. (2026) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2026.01.001 · Cited by 4
Engineering Salmonella as an immune-metabolic modulator of the tumor microenvironment
Varsha, K. K., & Dwidar, M. (2026) · Trends in biotechnology · doi:10.1016/j.tibtech.2026.01.010 · Cited by 4
Ran, H., Zhang, L., Ye, Y., Zhong, N., Wang, Y., Huang, B., Jiang, Y., Yang, X., Wei, Q., Tian, H., et al. (2026) · ACS Nano · doi:10.1021/acsnano.5c19758 · Cited by 4
Reprogramming Tumor‐Associated Neutrophils to Enhance Radio‐Immunotherapy
Yang, X., Lang, S., Liu, T., Zhao, X., Yan, Y., Zhang, Y., Feng, L., Liu, T., & Yang, K. (2026) · Advanced Materials · doi:10.1002/adma.73042 · Cited by 4
Oncolytic Therapy: Delivery System and New Therapeutic Strategies for Cancer
Jin, S., Zhang, Y., Zhou, Z., Zhang, Y., Yu, T., Xu, R., Xu, L., Zhang, J., Zhang, L., Yang, S., et al. (2026) · MedComm · doi:10.1002/mco2.70725 · Cited by 4
Özçelik, C. E., Tunç, N., Şen, S., & Şeker, U. Ö. Ş. (2026) · Chemistry - A European Journal · doi:10.1002/chem.202503523 · Cited by 4
Programmable living therapeutics for cancer immunotherapy
Deng, Z., Niu, L., Wang, Z., Jin, Y., Yao, Z., Wan, H., Guan, N., & Ye, H. (2026) · Cell chemical biology · doi:10.1016/j.chembiol.2026.04.007 · Cited by 5
Engineering commensal microbes for host health
Brown, E. A., Brevi, A., Zong, D. M., & Zarrinpar, A. (2026) · Cell Host & Microbe · doi:10.1016/j.chom.2026.05.025 · Cited by 4
Sun, Y., Zhao, Y., Han, K., Hu, W., Peng, G., Yi, S., Zhou, J., & Zheng, J. H. (2026) · Cell Reports Medicine · doi:10.1016/j.xcrm.2026.102913 · Cited by 4
“44 Bacteria are well adapted to sense and respond to the local environmental changes, and this capacity can be utilized for cancer diagnosis.”
Self-citationBugs as Cancer Drugs: Challenges and Opportunities
Daschner, P. J., Rasooly, A., & White, J. D. (2019) · Molecular and Cellular Biology · doi:10.1128/mcb.00206-19 · Cited by 4
DON‐Loaded Nanodrug‐T Cell Conjugates With PD‐L1 Blockade for Solid Tumor Therapy
Yang, X., Niu, X., Su, Y., Ye, X., Li, W., Zeng, W., Zhao, X., He, Z., Dong, Q., Zhou, X., et al. (2025) · Advanced Science · doi:10.1002/advs.202501815 · Cited by 4
Guo, Y., Sun, Y., Li, Z., Zuo, C., Liu, X., Chen, Y., Xun, Z., Liu, J., Yang, M. J., Min, J., et al. (2024) · International Journal of Cancer · doi:10.1002/ijc.35128 · Cited by 4
Self-citationCrunkhorn, S. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.54 · Cited by 4
Xu, H., Piao, L., Shen, X., & Liu, X. (2024) · Journal of Functional Foods · doi:10.1016/j.jff.2024.106017 · Cited by 4
Dysbiosis of the intestinal microbiota and colorectal cancer
Coleman, O., & Haller, D. (2020) · Colorectal Neoplasia and the Colorectal Microbiome · doi:10.1016/b978-0-12-819672-4.00007-6 · Cited by 2
Application of Bacterial Whole-Cell Biosensors in Health
Song, Y., Rampley, C. P. N., Chen, X., Du, F., Thompson, I. P., & Huang, W. E. (2019) · Springer eBooks · doi:10.1007/978-3-319-47405-2_136-1 · Cited by 4
Anti-cancer effect of interleukin-2 fused to flagellin expressed by tumor-targeting Salmonella
Tran, T. Q., Duysak, T., Kim, K., Dang, G. C., Yi, M., Choi, Y., Cho, J. H., Jeong, J., & Choy, H. E. (2025) · Oncogene · doi:10.1038/s41388-025-03504-y · Cited by 3
“1 – 3) [ 50 ]; In bacterial cancer therapy, where bacteria serve as vehicles for drug delivery, key challenges include expressing recombinant anti-cancer proteins in a soluble form and exporting them to the microenvironment.”
InfluentialSelf-citationInteractions Between Active Matters and Endogenous Fields
Lin, J., Guan, Q., Feng, J., Chen, S., Xu, L., Guan, J., & Sánchez, S. (2025) · Advanced Materials · doi:10.1002/adma.202503091 · Cited by 3
Bacteria modulate tumor-associated macrophages to combat cancer
Chen, Z., Li, J., Wang, J. J., Bai, Y., Zhang, Z., Chen, G., Cao, X. T., & Jin, D. (2025) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2025.104983 · Cited by 3
Tumor-Targeted Bacterial Vaccine Induces In Situ Immunogenic Cell Death for Cancer Immunotherapy
Wu, Y., Wu, N., Xu, Y., Yang, C., Zhou, H., Jiang, W., Shen, J., Liu, H., & Li, M. (2025) · Nano Letters · doi:10.1021/acs.nanolett.5c03938 · Cited by 3
Wu, Y., Zhou, M., Wan, Y., Wei, K., Ma, S., Cheng, L., Lin, T., He, L., He, Y., & Zhou, F. (2026) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1695187 · Cited by 3
“Moreover, an attenuated Salmonella Typhimurium strain has been engineered to produce Vibrio vulnificus flagellin B specifically within tumor tissues in mice, thereby activating M1-like macrophages and suppressing M2-like macrophages through the TLR4 signaling pathway (Zheng et al., 2017).”
Wang, X., Xu, W., Lu, Y., Yu, H., Zha, Z., & Zhang, X. (2026) · Advanced Science · doi:10.1002/advs.202523952 · Cited by 3
“For example, flagella on the surface of Salmonella can bind to TLRs and increase the immunogenicity of antigens [ 100 ].”
From Microbial Ecology to Functional Components in Microbe–Host Interactions
Wang, T., Wang, Z., Yang, X., & Zhang, L. (2026) · Biology · doi:10.3390/biology15080635 · Cited by 3
“In parallel, engineered delivery of beneficial microbial functional components [47] and the development of engineered microbes [48,49] have demonstrated therapeutic potential in preclinical and early clinical studies.”
InfluentialBibliometric analysis of genetically engineered bacteria in tumor therapy
Zhu, Y., Yin, Y., Li, Y., Wang, Q., Chen, Y., Gu, K., Yang, R., Zhou, M., & Chen, D. (2026) · Frontiers in Microbiology · doi:10.3389/fmicb.2026.1794032 · Cited by 3
Nguyen, D.-H., You, S.-H., Nguyen, K. V., Nguyen, P. T.-M., Ngo, H. T.-T., Tran, K. V., Tran, T. Q., Song, M., Hong, Y., & Min, J. (2026) · Theranostics · doi:10.7150/thno.129698 · Cited by 3
“Given the requirement of the HMGB1- TLR4-IFN-γ axis for tumor control, bacterial lipopolysaccharide (LPS) serves as a potent exogenous PAMP that facilitates the initiation of this innate cascade [13].”
InfluentialSelf-citationEngineering Bacteria for Medicine: Delivery, Diagnosis, and Therapy
Xia, S., Fu, G., Ding, X., Yang, W., Bai, R., Cai, Y., Zhang, J. X., Wei, Y., Han, C., Gao, Y., et al. (2026) · iMetaMed · doi:10.1002/imm3.70046 · Cited by 3
Engineering Proteus mirabilis improves antitumor efficacy via enhancing cytotoxic T cell responses
Zhang, H., Luo, Y., Zhao, X., & Liu, X. (2024) · Molecular Therapy Oncology · doi:10.1016/j.omton.2024.200770 · Cited by 3
“11,12 Immune checkpoint blockade therapy promotes T cell activation to stimulate antitumor responses and produce sustained cancer inhibition.”
BackgroundWang, Y., Bao, L., Liu, M., Tang, X., Liu, H., Liang, X., & Liu, Y. (2025) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/0118715303340093241227094242 · Cited by 3
Salmonella: Role in Internal and External Environments and Potential as a Therapeutic Tool
NAUGHTON, P. J., Naughton, V. R., & Dooley, J. S. G. (2024) · Applied Microbiology · doi:10.3390/applmicrobiol4040104 · Cited by 3
Human microbiota: role in cancer progression and therapy
Rais, A., Chand, P., Malik, M., & Prasad, T. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-96128-8.00006-7 · Cited by 3
Intratumoral bacteria in uveal melanoma: A case report
Escobar, K. V., Armijos, P. O., Milman, T., Shields, C. L., & Eagle, R. C. (2023) · American Journal of Ophthalmology Case Reports · doi:10.1016/j.ajoc.2023.101833 · Cited by 3
Infection by Salmonella enterica Promotes or Demotes Tumor Development
Hernández-Luna, M. A., Muñoz-López, P., Aguilar-González, C. A., & Luría-Pérez, R. (2018) · InTech eBooks · doi:10.5772/intechopen.75481 · Cited by 3
The Microbiome-TIME Axis: A Host of Possibilities
Ross, T. J., & Zhang, J. (2023) · Microorganisms · doi:10.3390/microorganisms11020288 · Cited by 3
“These pathways include modulation of the extracellular matrix [19], changes in cancerassociated fibroblasts [20], altered efficacy of innate and adaptive immune cells [21,22], and fluctuations in signaling molecules [23] (Figure 1).”
BackgroundAhmed, S., Oliva, G., Shao, M., Mekalanos, J. J., & Brenner, G. J. (2023) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2023.2262639 · Cited by 2
Applications of Nanomaterial‐Microorganism Hybrid Systems in the Treatment of Tumor
Khan, M. S., Baig, M. A., Tian, M., Li, B., Feng, G., Yang, R., Bai, Y., & Zheng, B. (2025) · Advanced Therapeutics · doi:10.1002/adtp.202400425 · Cited by 2
Global research trends in tumor-associated macrophage studies: a bibliometric analysis
Luan, A., Zhang, Y., Lu, Y., Zhao, G., & Yang, X. (2025) · Discover Oncology · doi:10.1007/s12672-025-02473-8 · Cited by 2
Wang, K., Xu, C., Chen, M., Yan, Y., Liu, N., Zhao, C., Liu, B., Liu, Y., Chen, J., Ding, X., et al. (2025) · Nano Research · doi:10.26599/nr.2025.94907612 · Cited by 2
Bacteria-Based Roles in Solid Tumors: Potential for Prevention and Treatment
Huang, J., Zhang, A., Sun, J., Fu, Y., Li, W., & Wang, Y. (2025) · Pathogens · doi:10.3390/pathogens14090874 · Cited by 2
“With bacterial engineering, the expression of apoptosis-inducing cytotoxic molecules can also effectively inhibit tumor growth, e.g., secretion of pro-apoptotic TNF family cytokines can selectively induce cytotoxicity to inhibit tumor development [107].”
Jakka, S. R., & Mugesh, G. (2026) · Angewandte Chemie International Edition · doi:10.1002/anie.202525502 · Cited by 2
Guo, B., Li, Z., Wang, Y., Li, B., Zhou, J., Chen, H., Li, M., Xu, Y., & Wu, X. (2026) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2026.115558 · Cited by 2
Biomaterials Based on Bacteria for Cancer Clinical Therapy
Liang, C., Sun, X., Xin, L., Yi, M., Ma, K., Li, Z., Ran, H., Zhu, W., Wang, Z., & Zhang, J. (2026) · Biomaterials Research · doi:10.34133/bmr.0350 · Cited by 2
“Using an attenuated Salmonella strain engineered to secrete Vibrio cholera flagellin B (FlaB) within tumor tissues [ 108 ], researchers effectively suppressed tumor growth and metastasis in murine models.”
Dai, M., Lin, Y., Gan, R., Shen, X., Park, S. Y., Lee, S., & Su, Q. (2026) · Microbiota Medicine Research · doi:10.1002/mmr3.70004 · Cited by 2
Self-citationJia, X., Xu, Y., Liu, X., Ye, M., Wang, F., Yang, X., Gao, X., Yu, J., & Liu, W. (2026) · Journal of Controlled Release · doi:10.1016/j.jconrel.2026.114945 · Cited by 2
Multiplexed Engineering of Salmonella Typhimurium for Targeted Cancer Therapies
Liu, X., Zhang, P. D., Chen, D., Xu, S., Wu, S. S., & Qiao, J. (2026) · ACS Synthetic Biology · doi:10.1021/acssynbio.6c00119 · Cited by 2
Food-Derived Limosilactobacillus fermentum GR-3 Enhances Anti–PD-1 Immunotherapy Efficacy
Xiang, W., Yang, Q., Ji, J., Qiao, H., Khan, A., Salama, E., Mao, C., Wu, Y., & Li, X. (2026) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-026-11048-0 · Cited by 2
“This aligns with preclinical models where attenuated Salmonella derivatives-or even their isolated structural components—amplify local TNF-α and IFN-γ production to enhance solid tumor control [ 69 , 70].”
Chen, M., Deng, Y., Fang, T., Luo, T., & Chen, G. (2026) · Bioactive Materials · doi:10.1016/j.bioactmat.2026.05.044 · Cited by 2
“Increased CRT exposure facilitates tumor antigen uptake and presentation by APCs, further strengthened by the presence of bacteria-derived substances in LyoBT, such as lipopolysaccharide (LPS) and flagellin [32,33].”
Toll-like receptors: versatile players in tumor
Yang, Y., & Pi, R. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1735188 · Cited by 2
Kim, S., kang, S., Kim, E., Han, M., Jeong, M., Kim, J., Jeon, H. J., & Lee, H. J. (2026) · Experimental Hematology and Oncology · doi:10.1186/s40164-026-00794-0 · Cited by 2
Metadata
- Authors
- Zheng, J. H., Nguyen, V. H., Jiang, S.-N., Park, S.-H., Tan, W., Hong, S. H., Shin, M. G., Chung, I.-J., Hong, Y., Bom, H.-S., Choy, H. E., Lee, S. E., Rhee, J. H., & Min, J.-J.
- Affiliations
- Chonnam National University (KR)
- City Of Hope National Medical Center (US)
- Department of Nuclear Medicine, Chonnam National University Medical School, Gwangju 61469, Republic of Korea.
- Korea Research Institute of Bioscience and Biotechnology (KR)
- Corresponding author
- Rhee, Joon Haeng
- Min, Jung-Joon
- ORCID
- Venue
- Science Translational Medicine
- Published
- 2017-02-08
- Volume
- 9
- Issue
- 376
- ISSN
- 1946-6234 (ISSN-L)
- 1946-6242
- OpenAlex
- W2586223583
- Cited by
- 588
- References
- 54
- Citations by year
- 2026: 76 · 2025: 81 · 2024: 85 · 2023: 73 · 2022: 71 · 2021: 65 · 2020: 55 · 2019: 34 · 2018: 30 · 2017: 18
- FWCI
- 27.48
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science Translational Medicine (publishedVersion)
- PubMed (publishedVersion)
- KRIBB Repository (submittedVersion)
- Funders
- Pioneer Research Center Program (2015M3C1A3056410)
- Bio & Medical Technology Development Program (NRF-2014M3A9B5073747)
- National Research Foundation of Korea
- Ministry of Science, ICT and Future Planning
- NRF (2012-0006072)
- Ministry of Health and Welfare, Republic of Korea (HI14C0187)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Bacterial Cancer Therapy
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Keywords
- cancer immunotherapy, Salmonella typhimurium, tumor-targeting bacteria, intratumoral macrophages, M1 macrophage polarization, TLR ligands
- MeSH terms
- Animals, Colonic Neoplasms, Flagellin, Genetic Engineering, Humans, Immunotherapy, Macrophages, Male, Mice, Inbred C57BL, Mice, Nude, Neoplasm Metastasis, Neoplasms, Phenotype, Salmonella typhimurium, Colony Count, Microbial, Signal Transduction, Cell Polarity, Xenograft Model Antitumor Assays, HCT116 Cells, Toll-Like Receptor 5
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.